Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation

AMH Clinical Trial

Official title: Serum Antimullerian Hormone Levels in Patients Who Underwent Hypogastric Artery Ligation

Status Completed

Clinical Trial Summary

To observe the effects of hypogastric artery ligation on serum antimullerian hormone levels.

Clinical Trial Description

To measure and compare serum antimullerian hormone levels in patients who underwent hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy and postpartum control. The procedures performed as an emergency life saving method during delivery. The reasons for hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy were obstetric hemorrhage mainly uterine atony.

The serum levels of antimullerian hormone were measured 6 months after the operations and compared with matching postpartum controls. Serum levels of FSH, LH, PRL and TSH were also measured 6 months after the operation. Further, antral follicle count measured along with the aforementioned blood tests. ;

Related Conditions & MeSH terms

• AMH

• NCT number: NCT03220594
• Study type: Observational [Patient Registry]
• Source: Kanuni Sultan Suleyman Training and Research Hospital
• Status: Completed
• Phase: N/A
• Start date: March 20, 2017
• Completion date: September 29, 2017